2017
A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial
KOJECKÝ, Vladimír, J. MATOUS, R. KEIL, Milan DASTYCH, Radek KROUPA et. al.Základní údaje
Originální název
A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial
Autoři
KOJECKÝ, Vladimír (203 Česká republika), J. MATOUS (203 Česká republika), R. KEIL (203 Česká republika), Milan DASTYCH (203 Česká republika, garant, domácí), Radek KROUPA (203 Česká republika, domácí), Z. ZADOROVA (203 Česká republika), M. VARGA (203 Česká republika), Jiří DOLINA (203 Česká republika, domácí), M. KMENT (203 Česká republika) a Aleš HEP (203 Česká republika, domácí)
Vydání
International Journal of Colorectal Disease, New York, Springer, 2017, 0179-1958
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30219 Gastroenterology and hepatology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.533
Kód RIV
RIV/00216224:14110/17:00098392
Organizační jednotka
Lékařská fakulta
UT WoS
000415692100014
Klíčová slova anglicky
Ascorbic acid; Colonoscopy; Magnesium citrate; Picosulfate sodium; Polyethylene glycol
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 3. 2018 17:06, Soňa Böhmová
Anotace
V originále
Purpose: The purpose of this study is to compare the efficacy and tolerability of polyethylene glycol (PEG) to sodium picosulfate/magnesium citrate (SPMC) and low-volume polyethylene glycol/ascorbic acid (PEGA) in a single- or split-dose regimen for colonoscopy bowel preparation. Methods: This was a prospective, randomized, endoscopist-blinded, multicentre study. Outpatients received either PEG or SPMC or PEGA in a single or a split dose before the colonoscopy. Quality and tolerability of the preparation and complaints during preparation were recorded. Results: Nine hundred seventy-three patients were analysed. Satisfactory bowel cleansing (Aronchick score 1 + 2) was more frequent when a split dose was used irrespective of the solution type (PEG 90.1 vs 68.8%, PEGA 86.0 vs 71.6%, SPMC 84.3 vs 60.2%, p < 0.001). SPMC was the best tolerated followed by PEGA (p < 0.006) and PEG as the worst (p < 0.001). Tolerability did not correlate with the regimen and amount of the solution used. Female gender is associated with a higher incidence of nausea, vomiting and pain (p < 0.029). Conclusions: Both PEG, PEGA and SPMC are fully comparable in terms of colonic cleansing when used in similar regimens. The split-dose preparation is more effective in all agents. SPMC and PEGA are better tolerated than PEG. The preparation regimen and/or the volume do not affect tolerability.